Coronavirus vaccine innovator suggests return to normal by ‘winter next year’

Professor Ugur Sahin, chief executive of BioNTech, said it was “absolutely essential” to have a high vaccination rate before autumn next year to ensure a return to normal life next winter
Coronavirus vaccine innovator suggests return to normal by ‘winter next year’

A patient being given a dose of a coronavirus vaccine produced by BioNTech (BioNTech/PA)

One of the scientists behind the first Covid-19 vaccine to clear interim clinical trials has said the impact of the jab will kick in next summer, and normality should return by next winter.

Professor Ugur Sahin, chief executive of BioNTech, said it was “absolutely essential” to have a high vaccination rate before autumn next year to ensure a return to normal life next winter.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited